Literature DB >> 15919649

Drug eluting stents in 2005.

A H Gershlick1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15919649      PMCID： PMC1876362          DOI： 10.1136/hrt.2005.060277

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  10 in total

1.  The ARTS study (Arterial Revascularization Therapies Study).

Authors:  P W Serruys; F Unger; B A van Hout; M J van den Brand; L A van Herwerden; G A van Es; J J Bonnier; R Simon; J Cremer; A Colombo; C Santoli; M Vandormael; P R Marshall; O Madonna; B G Firth; A Breeman; M A Morel; P G Hugenholtz
Journal:  Semin Interv Cardiol       Date:  1999-12

2.  Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery.

Authors:  D I Axel; W Kunert; C Göggelmann; M Oberhoff; C Herdeg; A Küttner; D H Wild; B R Brehm; R Riessen; G Köveker; K R Karsch
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

3.  Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

Authors:  Joachim Schofer; Michael Schlüter; Anthony H Gershlick; William Wijns; Eulogio Garcia; Erick Schampaert; Günter Breithardt
Journal:  Lancet       Date:  2003-10-04       Impact factor: 79.321

Review 4.  ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?

Authors:  Lutz Buellesfeld; Eberhard Grube
Journal:  Herz       Date:  2004-03       Impact factor: 1.443

5.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

6.  Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.

Authors:  Anthony Gershlick; Ivan De Scheerder; Bernard Chevalier; Amanda Stephens-Lloyd; Edoardo Camenzind; Christian Vrints; Nicolaus Reifart; Luc Missault; Jean-Jacques Goy; Jeffrey A Brinker; Albert E Raizner; Philip Urban; Alan W Heldman
Journal:  Circulation       Date:  2004-01-26       Impact factor: 29.690

7.  Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).

Authors:  Myeong-Ki Hong; Gary S Mintz; Cheol Whan Lee; Jong-Min Song; Ki-Hoon Han; Duk-Hyun Kang; Jae-Kwan Song; Jae-Joong Kim; Neil J Weissman; Neal E Fearnot; Seong-Wook Park; Seung-Jung Park
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

8.  The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

Authors:  Erick Schampaert; Eric A Cohen; Michael Schlüter; François Reeves; Mouhieddin Traboulsi; Lawrence M Title; Richard E Kuntz; Jeffrey J Popma
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

9.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Authors:  Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

10.  Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.

Authors:  Antonio Colombo; Janusz Drzewiecki; Adrian Banning; Eberhard Grube; Karl Hauptmann; Sigmund Silber; Dariusz Dudek; Stephen Fort; Francois Schiele; Krysztof Zmudka; Giulio Guagliumi; Mary E Russell
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690
  10 in total
  2 in total

Review 1.  Mammalian target of rapamycin: a central node of complex signaling cascades.

Authors:  Yoh Dobashi; Yasutaka Watanabe; Chihiro Miwa; Sakae Suzuki; Shinichiro Koyama
Journal:  Int J Clin Exp Pathol       Date:  2011-06-14

2.  Novel Fabrication of MicroRNA Nanoparticle-Coated Coronary Stent for Prevention of Post-Angioplasty Restenosis.

Authors:  Hui-Lian Che; In-Ho Bae; Kyung Seob Lim; Saji Uthaman; In Taek Song; Haeshin Lee; Duhwan Lee; Won Jong Kim; Youngkeun Ahn; In-Kyu Park; Myung-Ho Jeong
Journal:  Korean Circ J       Date:  2016-01-14       Impact factor: 3.243
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.